Videos de Experimentos Relacionados
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Progression-, aggression-, survival and outcome characteristics in Merkel cell carcinomas in 176 patients.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery·2025
Same author
Basal cell carcinoma risk and solar UV exposure in occupationally relevant anatomic sites: do histological subtype, tumor localization and Fitzpatrick phototype play a role? A population-based case-control study.
Journal of occupational medicine and toxicology (London, England)·2020
Same author
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.
The British journal of dermatology·2018
Same author
Prospective multicentre cohort study on 9154 surgical procedures to assess the risk of postoperative bleeding - a DESSI study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author
[In honor of Professor Dr. Dr. h.c. G. K. Steigleder on the occasion of his 90th birthday].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2015
Same journal
Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.
Lancet (London, England)·2026
Same journal
Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.
Lancet (London, England)·2026
Same journal
Inherited retinal degenerations: clinical phenotypes and emerging therapies.
Lancet (London, England)·2026
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026